Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4.
The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.
Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.
Quetiapine Fumarate for the Treatment of Multiple Sclerosis: Focus on Myelin Repair.
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
Brain-derived neurotrophic factor and its clinical implications.
Comparison of Routine Brain Imaging at 3 T and 7 T.
The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
Occupational attainment as a marker of cognitive reserve in multiple sclerosis.
Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis.
The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Emerging role of long noncoding RNAs in autoimmune diseases.
T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients.
Cladribine in multiple sclerosis: pitfalls in a new treatment landscape.
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
FTY720 induces apoptosis of m2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels.
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
Intrathecal versus Oral Baclofen; a Matched Cohort Study of Spasticity, Pain, Sleep, Fatigue and Quality of Life.
Pages
« first
‹ previous
…
330
331
332
333
334
335
336
337
338
…
next ›
last »